Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant changes detected on the page; core study details, eligibility criteria, and interventions remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T21:06:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:33:48.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, indicating a version upgrade with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:00.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and Back to Top was removed; overall changes are minor and do not affect core content or user-facing information.
    Difference
    0.2%
    Check dated 2025-09-14T19:01:05.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T14:26:50.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates to related medical topics such as colorectal cancer. However, many previous details, including specific drug information and genetic resources, have been removed.
    Difference
    2%
    Check dated 2025-08-31T11:43:08.000Z thumbnail image

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.